000 | 01816 a2200505 4500 | ||
---|---|---|---|
005 | 20250517201624.0 | ||
264 | 0 | _c20181001 | |
008 | 201810s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2018.01.171 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Xiaoping | |
245 | 0 | 0 |
_aAnti-migraine and anti-depression activities of Tianshu capsule by mediating Monoamine oxidase. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cApr 2018 |
||
300 |
_a275-281 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnalgesics _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntidepressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMedicine, Chinese Traditional |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aPlant Preparations _xadministration & dosage |
650 | 0 | 4 | _aPrimary Cell Culture |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSwimming |
700 | 1 | _aZhu, Fangfang | |
700 | 1 | _aZhou, Jun | |
700 | 1 | _aChang, Xiujuan | |
700 | 1 | _aLi, Liang | |
700 | 1 | _aHu, Hanfei | |
700 | 1 | _aWang, Zhenzhong | |
700 | 1 | _aXiao, Wei | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 100 _gp. 275-281 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2018.01.171 _zAvailable from publisher's website |
999 |
_c28081350 _d28081350 |